TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Total Costs & Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+22.2%
5Y CAGR+39.9%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+22.2%/yr
Annual compound
5Y CAGR
+39.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.3x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$146.14M+6.2%
2024$137.64M+20.2%
2023$114.51M+42.8%
2022$80.17M+36.4%
2021$58.78M+115.2%
2020$27.32M+92.2%
2019$14.21M-